Changelings were raised regarding the feasibility of appli cation envisioned by researchers in the field of molecular nano technology culminated into a development of new tech nique in research which rose in all the stream of biology and information technology. The paper depicts about the use of nano technology in multifunctional areas of clinical practices briefly. It has now become possible to overcome many biological, biophysical, and biomedical barriers in health sector. The paper has not only highlighted the importance of nanotechnology in diagnostic, imaging, therapeutic relation ships but also focused on an interrelationship of nano technology with other chains of research fields such as; infor mation technology, biotechnology, and medicine.
INTRODUCTION
During the last 5000 years, unique cultures have come into existence as humans continuously attempted to have a better life for themselves and the society around them. Particularly in the last 200 years, the society got transformed from purely agriculture to industrial, and then to information with different manifestations. The Industrial Revolution in the 18th century paved way for economic development making the life better with new opportunities and a large-scale employment. Information Technology (IT) revolutionized our lifestyle further and became a major part of economy. In addition to the industrially developed countries, the economy grew faster in the developing countries also due to the information revolution. The IT revolution taking the advantage of large skilled human resource further added to the economic prosperity. Recent developments in bioand nanotechnologies and their convergence with IT opened up greater opportunities for the future.
The IT and communication technology have already converged leading to Information and Communication Technology (ICT). Information technology, combined with biotechnology, has led to bioinformatics. Similarly, photonics has grown out from the labs to converge with classical electronics and microelectronics to bring in new high speed options in consumer products shown in Figure 1 . Flexible and unbreakable displays using thin layer of film on transparent polymers have emerged as new symbols of entertainment and media tools. Nanotechnology is the field of the future that will replace microelectronics and many fields with tremendous application potential in the areas of medicine, electronics and material science. The confluence of these newly acquired capabilities, coupled with advances in imaging, bioinformatics, and systems biology, holds tremendous promise for answering some of biology's most challenging biochemical and genetic questions.
What is Nanotechnology?
Nanotechnology is a new area of science that involves working with materials and devices that are at the nanoscale dimensions, in various fields, such as electronics, computer technology, and cosmetics industry and in drug delivery or medical diagnostics. The birth of nanotechnology is usually associated with a talk entitled 'Plenty of room at the bottom' presented by Nobel-prize winner Richard P Feynman to the American Physical Society in Pasadena on December 1959, whose text has appeared in the book entitled 'The Great Explainer: The story of Richard Feynman'. Nanotechnology has the potential for major scientific and practical breakthroughs. A nanometer is billionth of a meter, that is, about 1/80,000 of the diameter of a human hair, or ten times the diameter of a hydrogen atom. Nanotechnology alters the way we think, it blurs the boundaries between physics, chemistry, and biology; the elimination of these boundaries will pose many challenges and new directions for the organization of education and research. It manipulates the chemical and physical properties of a substance at the molecular level. These practical applications explain why nanomaterials are gathering great interest in the scientific and economic spheres. Although much of nanotechnology is still in the research and development phase, nanomaterials are expected to be used in a wide variety of applications ranging from biomedical drug delivery to electronics, pollution remediation, and less toxic modes of manufacturing. 2 Many scientists and policy-makers see nanotechnology as the wave of the future, and, as a result, investment in nanotechnology has continued to increase. The role of nanobiotechnology in molecular diagnostics and personalized medicine is depicted in Figure 2 .
Nanotechnology in Biology
Although nanomaterials are similar to components in biological system in respect to size and shape, the advanced applications possible through bionanotechnology distinguishes it from biophysics or structural biology or virology. This is the same distinction that separates biotech nology from molecular and cell biology or physics from electronics and chemical engineering from chemistry. Recognizing that nanotechnology and biology share common length scales at this level, we can see how the combination of the two creates the opportunity to produce and apply novel hybrid structures, materials, and devices that exploit the distinctive features of both. Exploitation spans the use of nanomaterials as tools in fundamental biological research, the development of novel approaches to diagnose, and treat disease as well as new ways to generate energy or clean up the environment. This article focuses on developing nanotechnology to address healthcare-related applications in both therapeutic and diagnosis methods. Medical advancements are constantly being researched. Technologies, such as nanoparticles are being used to improve or replace today's therapies. Nanoparticles have advantages over today's therapies because they can be engineered to have certain properties or to behave in a certain way. These properties include size and shape, solubility and targeting.
Advantages of Nanosize
The most important advantage of nanomaterials is our ability to synthesize them in required size, shape, and biocompatibility in relation to biological systems. Nanoscale devices and components are of the same basic size as biological entities (Fig. 3) . Nanoscale constructs are smaller than human cells (10,000-20,000 nm in diameter) and organelles and similar in size to large biological macromolecules and enzymes, such as hemoglobin (~5 nm in diameter) and lipid bilayer (~6 nm thick). Nanoparticles smaller than 20 nm in diameter can transit through blood vessel walls and can also penetrate the blood-brain barrier, testis barrier, or the stomach epithelium. [4] [5] [6] [7] [8] [9] Magnetic nanoparticles can be used in imaging metastatic lesions in lymph nodes because of their ability to exit the systemic circulation through the permeable vascular epithelium. 3 To be suitable as a delivery platform, the size of nanoparticles must be small enough to avoid rapid filtration by the spleen, with filaments spaced at roughly 200 nm, 10 which serve as a meshwork for phagocytic cells. 11 Similarly, to traverse the liver, the particles must be small enough to pass through the organ's 150 to 200 nm sized fenestrae and avoid the Kupffer cell-lined sieve plates. 12 Drug carrying liposomes are believed to have increased life spans, related in part to their ability to extravasate through splenic and liver fenestrae. 
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The size of nanoscale devices also allows them to interact readily with biomolecules on the cell surface and within the cell, often in ways that do not alter the behavior and biochemical properties of those molecules.
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Solubility Matters
Solubility of nanoparticles is as important as its size. Modification of the outer layer of nanoparticles permits the covalent binding of a large variety of chemical, molecular and biological entities. This alteration in the corona confers advantageous properties to the particle such as increased solubility and biocompatibility. Atta ching hydrophilic polymers to the surface, such as polyethylene glycol (PEG), greatly increases the hydration (i.e. solubility) of the nanoparticles and can protect attached proteins from enzymatic degradation when used for in vivo applications. 15 This property of nanoparticles is perhaps most applicable in drug discovery and delivery.
Targeting Matters
One of the earliest examples of applying nanotechnology to solving problems in biology was the use of liposomes as drug delivery vehicles. 16 The liposomes of size 50 to 70 nm in diameter are taken up rapidly by macrophages, which then carry the liposome and drug to the site of fungal colonization. A liposomal formulation of the potent but toxic antifungal agent amphotericin B has revolutionized the treatment of life-threatening, systemic, fungal infections in immune compromised patients by allowing patients to receive normally lethal doses of amphotericin B with minimal risk of toxicity. 17 Cancer therapy has benefited from the use of liposomal doxorubicin, a formulation that again increases the therapeutic index of the active agent through a combination of passive tumor targeting and reduced toxicity. 18 In this case, coating the liposome with PEG significantly decreases uptake by macrophages and allows the liposomes to concentrate in tumors by escaping from the leaky vasculature surrounding solid tumors 18 through a phenomenon known as the enhanced permeation and retention effect.
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DIAGNOSIS
Nanotechnology has been described as a general purpose technology. Development of nanotechnology will provide clinical medicine with a range of new diagnostic and therapeutic opportunities, such as drug delivery platforms. 22 Contrast enhanced image agents, 23 chip-based nanolabs capable of monitoring 24 and manipulating individual cells 25 and nanoscale probes that can track the movements of cells 26 and individual molecules 27 as they move about in their environment (Fig. 4) . Such an unprecedented ability to observe and influence complex systems in vivo and in real-time provides detailed information about the fundamental mechanisms and signalling pathways involved in the progression of disease and greatly extends the existing toolset for drug delivery and noninvasive drug monitoring. Nanoparticles such as manganese, polystyrene, silica, titanium oxide, 
Medical Imaging
Nanoparticles can provide significant improvements in traditional imaging of cells and tissues using fluo rescence microscopy as well as in modern magnetic reso nance imaging of various regions of the body. 29 Particle charge, size, shape, and hydrophilicity remain among the most important properties of nanoparticles for effective delivery to the desired target. Polyethylene glycol molecules have been investigated extensively as an effective means to provide hydrophilic 'stealth' properties, commonly yielding reduced nonspecific adsorption of serum proteins in vivo, thus producing longer circulation times. 30 Conversely, positively charged nanoparticles are being designed for enhancing endocytosis or phagocytosis for cell labelling. 31 Metallic nanoparticles possess immense potential as X-ray contrast imaging agents owing to their potent X-ray absorption and low toxicity profiles observed over short durations in animals.
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Medical Diagnosis
The accurate targeting and quantification of molecules indicative of cellular disorders at the single-molecule level is a demanding task for analysis systems. The combi nation of nanoparticles with other nanotechnologybased materials has the potential to address this emer ging challenge and provide technologies that enable diagnosis at the level of single cells and single molecules. 34 Antibodies, peptides, proteins, and nucleic acids are biologic molecules which could be linked covalently to functionalized nanoparticles which have been developed as nanoprobes for molecular detection. These functionalized nanoparticles can provide a direct rapid method of detection of infectious diseases and viruses in particular with high sensitivity.
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Nanotechnology-based Medical Diagnosis Techniques under Development
• A method for detecting cancer cells in the bloodstream is being developed using nanoparticles called nanoflares. The nanoflares are designed to bind genetic targets in cancer cells, and generate light when that parti cular genetic target is found.
• A method for early diagnosis of brain cancer under development uses magnetic nanoparticles and nuclear magnetic resonance (NMR) technology. The magnetic nanoparticles attach to particles in the blood stream called microvesicles which originate in brain cancer cells. Nuclear magnetic resonance is then used to detect these microvesicles/magnetic nanoparticle clusters, allowing an early diagnosis.
• Carbon nanotubes and gold nanoparticles are being used in a sensor that detects proteins indicative of oral cancer.
• Silver nanorods in a diagnostic system are being used to separate viruses, bacteria, and other microscopic components of blood samples, allowing clearer Raman spectroscopy signals of the components. This method has been demonstrated to allow identification of viruses and bacteria in less than an hour.
Cytogenetic
Cytogenetics in a broader sense rather than the classical is used mainly to describe the chromosome structure and identify abnormalities related to disease. In the age of molecular biology, it is also referred to as molecular cytogenetic. The localization of specific gene probes by fluorescent in situ hybridization (FISH) combined with conventional fluorescence microscopy has reached its limit. Within the last 10 years or so, however, there has been a growing relationship between nanoscience and fluorescent biological imaging. 37 Applications of fluorescent imaging have generated a tremendous drive to develop new probes for tagging molecules, enabling changes in their localization, concentration and activities to be documented, for example quantum dot (QD) FISH. 38 Fluorescent in situ hybridization techniques have thus continuously been adapted but, as with many fluorescence microscopy applications, phase limitations imposed by the use of organic fluorophores. These include the number of available fluorochromes and their broad emission spectra that make multicolor experiments difficult to resolve because of spectrum overlapping and photobleaching. Thus, QDs, are most suitable candidates for the study of chromosomes through adaptations of FISH protocols, particularly as the conjugation of QDs and streptavidin is already widely reported. Indeed, QD-FISH has the potential to revolutionize. Fluorescent in situ hybridization by overcoming many of the inherent difficulties from the use of organic fluorochromes.
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TREATMENT
Drug Delivery
Medical therapies have become more tailored to both specific diseases and to patients on an individual basis in recent years. Most pharmaceutical agents have primary targets within cells and tissues; ideally, these agents should be preferentially delivered to their sites of action within the cell. Selective subcellular delivery is likely to have considerable therapeutic benefit. 41 Developed nanoscale particles or molecules improve the bioavailability of the drug delivery both at specific places in the body and over a longer period of time. 42 Drug delivery systems are based on nanoparticles which have a mesoscopic size range of 5 to 200 nm, allowing their unique interaction with biologic systems at the molecular level to produce multiple advantages, for example, reduced rate of drug clearance, alteration of the pharmacokinetics and biodistribution of the drug, passage of drugs through cell membranes and into the cell cytoplasm, and regulated drug release which can avoid the tissue damage caused by some drugs.
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Oncology
Cancer therapies are currently limited to surgery, radiation and chemotherapy. All three methods risk damage to normal tissues or incomplete eradication of the cancer. Nanotechnology provides researchers with the opportunity to study and manipulate macromolecules in real time and during the earliest stages of cancer progression. Nanotechnology can provide rapid and sensitive detection of cancer-related molecules, enabling scientists to detect molecular changes even when they occur only in a small percentage of cells. Nanotechnology also has the potential to generate entirely novel and highly effective therapeutic agents. To produce minimal damage to normal tissue, therapeutic drugs have been conjugated with monoclonal antibodies that selectively bind to antigens or receptors which are usually abundantly or uniquely expressed on the tumor cell surface. Nanoparticles have been shown to overcome both cellular-and noncellular-based drug resistance and to increase selectivity of drugs toward cancer cells while reducing their toxicity toward normal tissues. 44 Several types of anticancer drugs, such as liposome-based formulations of several anticancer agents (stealth liposomal doxorubicin, liposomal doxorubicin, and liposomal daunorubicin), have been approved for the treatment of metastatic breast cancer. 45 The study carried by Rasmussen JW et al showed destruction of tumor cells by using a zinc oxide nanoparticle. The study claimed that the nanoparticles of ZnO or any other metal oxide could be a choice of treatment. However, there are still many aspects to be cleared before using them in the form of treatment because over dosage may lead to toxicity. 46 The relevance of hyperthermia induced by magnetic nanoparticles in the treatment of gliomas has shown positive results in both preclinical and clinical assays. Magnetic hyperthermia consists of heat generation in the region of the tumors through the application of magnetic nanoparticles subjected to an alternating magnetic field, thus proving a beneficial treatment for malignant gliomas, 47 Georgios A Sotiriou et al used silica-coated Au/Fe 2 O 3 nano aggregates to kill cancerous cell by applying the phenomena of photo thermal effect. The SiO 2 shell facilitates dispersion and prevents the reshaping or coalescence of Au particles during laser irradiation, thereby allowing their use in multiple treatments. 48 Green synthesis of silver nanoparticles capped with selective biomolecules was shown to have anticancer properties, It was found that both silver nanoparticles and its capping biomolecules have antiproliferative effects in colon cancer treatment.
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Application of Nanotechnology in Stem Cell
Nanotechnology and stem cells are two of the most promising research areas in recent times. The recent application of nanotechnology in stem cell research promises to open new avenues in regenerative medicine. Though stem cells hold a great potential for the treatment of many injuries and degenerative diseases, several obstacles need to be overcome before their therapeutic application can be served. These include development of advanced techniques to monitor micro environmental signals and also track and guide the transplanted stem cells. Thus, nanotechnology can be a valuable tool to track and image stem cells, to drive their differentiation into specific cell lineages, and ultimately to understand their biology. Quantum dots (QDs) and a range of other nanomaterials have been used in stem cell research for in vitro and in vivo bioimaging. The labelling of human mesenchymal stem cells (hMSCs) with RGD-conjugated QDs during self-replication and multiline age differentiations into osteogenic, chondrogenic and adipogenic cells. Quantum dot labeled hMSCs remained viable as unlabeled hMSCs from the same subpopulation. 50 These findings suggest the use of 51, 52 In particular, hybrid nanobiomaterials, which can be used to fabricate scaffolds and implantable substrates for the treatment of neurological disorders, such as Alzheimer's disease, Parkinson's disease, and spinal cord injuries, are now being intensively investigated in order to elicit specific behaviors from stem cells, including differentiation, migration and proliferation. Solanki et al in 2013 developed arrays of graphenenanoparticle hybrid nanostructures for the differentiation and growth of human neural stem cells (hNSCs). More importantly, these graphene-hybrid nanostructures bring the formation of highly aligned axons from the differentiating hNSCs to fruition. This research result can provide an engineered microenvironment to the neural stem cells NSCs through novel nanomaterial construct. This new technology can specifically control the axonal alignment and growth of NSC-derived neurons for the development of more effective treatments for spinal cord injuries.
53
OTHER APPLICATIONS
Application of Nanoparticles for Discovery of Biomarkers
There is an urgent need to discover novel biomarkers that provide sensitive and specific detection of early stage disease when it is highly treatable. Currently, available molecular diagnostic technologies have been used to detect biomarkers of various diseases. During the past few years, the potential of nanotechniques and nanomaterials in biomarker discovery has been extensively studied. 54, 55 Such emerging approaches are advantageous due to their high sensitivity, minimum sample requirements, accuracy, real-time sensing, and simplicity of the instruments, low cost and potential diagnostic applications. Among other nanomaterials, QDs, gold nanoparticles (AuNPs), carbon nanotubes (CNTs) and silicon nanowires are promising candidates for biomarker detection and discovery. In addition, there are other potential nanotechniques which include microcantilevers, microfluidics, gold nanowires, or silver nanomechanical resonators. 56 Clinical applications of nanodiagnostics: Some of the clinical applications of nanodiagnostics are mentioned along with technologies elsewhere in report. 57 The report describes some examples of the use of nanodiagnostics in diagnosing cancers, infections and neurological disorders.
Nanobiosensors
Nanobiosensors are nanosensors used for detection of chemical or biological materials. Nanomaterials are exquisitely sensitive chemical and biological sensors. 20 These sensors can be electronically gated to respond to the binding of a single molecule. Prototype sensors have demonstrated the detection of nucleic acids, proteins and ions. These sensors can operate in the liquid or gas phase, opening up an enormous variety of downstream applications. The detections schemes use inexpensive low voltage measurements and detect binding events directly, so there is no need for costly, complicated, and time consuming labelling methods, such as fluorescent dyes or the use of bulky and expensive optical detection systems. As a result, these sensors are inexpensive to manufacture and are portable. It may even be possible to develop implantable detection and monitoring devices on the basis of these detectors.
CONCLUSION
The visions described in this article may sound unlikely, implausible, or even heretic. Yet, the theoretical and applied research to turn them into reality is progressing rapidly. Nanotechnology will change healthcare and human life more profoundly than many developments of the past. As with all technologies, nanotechnology carries a significant potential for misuse and abuse on a scale and scope never seen before. However, they also have potential to bring about significant benefits, such as improved health, better use of natural resources, and reduced environmental pollution. These truly are the days of miracle and wonder. Once nanomechanics available, the ultimate dream of every healer, medicine man, and physician throughout recorded history will, at last become a reality. Programmable and controllable microscale robots, comprised of nanoscale parts fabricated to nanometer precision, will allow medical doctors to execute curative and reconstructive procedures in the human body at the cellular and molecular levels. Nanomedical physicians of the 21st century will still make good use of the body's natural healing powers and homeostatic mechanisms,
